Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABUS compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ABUS
Arbutus Biopharma Corp
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABUS
Arbutus Biopharma Corp
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ABUS, solid
LLY, dashed
ABUS
Arbutus Biopharma Corp
Change
4.01
· pre 3.97
· delayed
Mkt cap
$791.4M
Revenue
$1M
Q2 FY26
Revenue
$14M
FY25
LLY
ELI Lilly & Co
Change
1,418.01
· pre 1,403.18
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
ABUS
Arbutus Biopharma Corp
vs
LLY
ELI Lilly & Co
4.01
pre 3.97
delayed
Price
1,418.01
pre 1,403.18
delayed
$791.4M
Mkt cap
$1.3T
Q2 FY26
$1M
Revenue
$24.4B
Q3 FY26
FY25
$14M
Revenue
$65.2B
FY25
Change
Change
ABUS
4.01
vs
LLY
1,418.01
Pre-market
Nov 3 '26
delayed